<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet href="/rss.css" type="text/css"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/"
    xmlns:cc="http://web.resource.org/cc/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:extra="http://www.w3.org/1999/xhtml"
    xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
    <channel rdf:about="http://www.biomedcentral.com/feeds/latestarticles/journal?journal=bmcmusculoskeletdisord&amp;quantity=&amp;format=rss&amp;version=">
        <title>BMC Musculoskeletal Disorders - Latest Articles</title>
        <link>http://www.biomedcentral.com/bmcmusculoskeletdisord/</link>
        <description>The latest research articles published by BMC Musculoskeletal Disorders</description>
        <dc:date>2012-05-31T00:00:00Z</dc:date>
        <items>
            <rdf:Seq>
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2474/13/85" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2474/13/84" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2474/13/83" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2474/13/82" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2474/13/81" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2474/13/80" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2474/13/79" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2474/13/78" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2474/13/77" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2474/13/76" />
                            </rdf:Seq>
        </items>
                 <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </channel>
        <item rdf:about="http://www.biomedcentral.com/1471-2474/13/85">
        <title>Malignancy Validation in a United States Registry of Rheumatoid Arthritis Patients</title>
        <description>Background:
Physician reporting is commonly used to ascertain adverse events or outcomes measured in epidemiologic studies. However, little is known on the accuracy of physician reported malignancies compared to pertinent medical record review in large cohort studies.
Methods:
The Consortium of Rheumatology Researchers of North America (CORRONA) registry gathers physician-completed questionnaires for rheumatoid arthritis (RA) patients, including request for information on incident malignancies, approximately every three months. For incident malignancies reported from October 1st, 2001, through December 31st, 2007, we retrospectively requested completion of a Targeted Adverse Event (TAE) form for additional information as well as primary source documents to adjudicate the malignancy reports. CORRONA has employed a prospective request for source documentation for these events since 2008. We classified each malignancy as definite, probable, possible, or not a malignancy.
Results:
From 20,837 RA patients enrolled in CORRONA, 461 incident malignancies were initially reported on physician questionnaires. After review of returned source documents with adjudication, 234 were deemed definite, 69 probable, 101 possible, and 57 not an incident malignancy. The positive predictive value (PPV) of initial physician report of a malignancy versus &quot;definite or probable&quot; malignancy based on adjudication was 0.66 (95% CI 0.61 - 0.70). The PPV was 0.68 (95% CI 0.63 - 0.72) when the subsequent TAE form also confirmed the presence of malignancy. When possible malignancies were included, the PPV of physician-reported malignancies without a subsequent TAE form increased to 0.86 (0.83 - 0.89), and with a subsequent TAE form, 0.89 (0.85-0.91).
Conclusion:
Twelve percent of initial physician reports of incident malignancy could not be confirmed with review of source documents. The most common reason for lack of confirmation was inability to obtain documents or insufficient data in source materials. These results suggest that timely collection of relevant medical records and an adjudication process are required to improve the accuracy of cancer reporting in epidemiologic studies.</description>
        <link>http://www.biomedcentral.com/1471-2474/13/85</link>
                <dc:creator>Mark Fisher</dc:creator>
                <dc:creator>Victoria Furer</dc:creator>
                <dc:creator>Marc Hochberg</dc:creator>
                <dc:creator>Jeffrey Greenberg</dc:creator>
                <dc:creator>Joel Kremer</dc:creator>
                <dc:creator>Jeff Curtis</dc:creator>
                <dc:creator>George Reed</dc:creator>
                <dc:creator>Leslie Harrold</dc:creator>
                <dc:creator>Daniel Solomon</dc:creator>
                <dc:source>BMC Musculoskeletal Disorders 2012, null:85</dc:source>
        <dc:date>2012-05-31T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2474-13-85</dc:identifier>
                                <prism:require>/content/figures/1471-2474-13-85-toc.gif</prism:require>
                <prism:publicationName>BMC Musculoskeletal Disorders</prism:publicationName>
        <prism:issn>1471-2474</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>85</prism:startingPage>
        <prism:publicationDate>2012-05-31T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2474/13/84">
        <title>Embracing additive manufacture: implications for foot and ankle orthosis design</title>
        <description>Background:
The design of foot and ankle orthoses is currently limited by the methods used to fabricate the devices, particularly in terms of geometric freedom and potential to include innovative new features. Additive manufacturing (AM) technologies, where objects are constructed via a series of sub-millimetre layers of a substrate material, may present the opportunity to overcome these limitations and allow novel devices to be produced that are highly personalised for the individual, both in terms of fit and functionality.Two novel devices, a foot orthosis (FO) designed to include adjustable elements to relieve pressure at the metatarsal heads, and an ankle foot orthosis (AFO) designed to have adjustable stiffness levels in the sagittal plane, were developed and fabricated using AM. The devices were then tested on a healthy participant to determine if the intended biomechanical modes of action were achieved.
Results:
The adjustable, pressure relieving FO was found to be able to significantly reduce pressure under the targeted metatarsal heads. The AFO was shown to have distinct effects on ankle kinematics which could be varied by adjusting the stiffness level of the device.
Conclusions:
The results presented here demonstrate the potential design freedom made available by AM, and suggest that it may allow novel personalised orthotic devices to be produced which are beyond the current state of the art.</description>
        <link>http://www.biomedcentral.com/1471-2474/13/84</link>
                <dc:creator>Scott Telfer</dc:creator>
                <dc:creator>Jari Pallari</dc:creator>
                <dc:creator>Javier Munguia</dc:creator>
                <dc:creator>Kenny Dalgarno</dc:creator>
                <dc:creator>Martin McGeough</dc:creator>
                <dc:creator>Jim Woodburn</dc:creator>
                <dc:source>BMC Musculoskeletal Disorders 2012, null:84</dc:source>
        <dc:date>2012-05-29T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2474-13-84</dc:identifier>
                                <prism:require>/content/figures/1471-2474-13-84-toc.gif</prism:require>
                <prism:publicationName>BMC Musculoskeletal Disorders</prism:publicationName>
        <prism:issn>1471-2474</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>84</prism:startingPage>
        <prism:publicationDate>2012-05-29T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2474/13/83">
        <title>Accuracy and reproducibility of a retrospective outcome assessement for lumbar spinal stenosis surgery</title>
        <description>Background:
Retrospective assessment of surgery outcome is considered problematic. The aims of this study were to evaluate the reproducibility and accuracy of a retrospective outcome assessment of lumbar spinal stenosis surgery with reference to prospective outcome scale measurements.MethodOutcome of surgery from 100 lumbar spinal stenosis (LSS) patients was evaluated retrospectively from patient files of a 3-month outpatient visit performed according to a standard clinical protocol by two independent researchers. In the retrospective analysis, outcome was graded as 2=good if the clinical condition had clearly improved, 1=moderate if it had just slightly improved, 0=poor if it had not improved or was even worse than before the surgical treatment (Retrospective 3-point scale). A prospectively assessed Oswestry Disability Index questionnaire (ODI), Visual analogue pain scale (VAS) and a patient satisfaction questionnaire were used as references of standards. Reproducibility of the measurements was evaluated.
Results:
The retrospective 3-point scale correlated with ODI (r = 0.528; P &lt; 0.001) and VAS (r = 0.368; P &lt; 0.001). The agreement was better in the good and poor outcome than in the moderate outcome.  Retrospective 3-point scale demonstrated substantial intra-rater and inter-rater repeatability (kappa = 0.682, P &lt; 0.001 and kappa=0.630, P &lt; 0.001, respectively).
Conclusions:
Retrospective assessment of spinal surgery outcome is highly reproducible. Accuracy is highest in the patients with poor and good surgical result.</description>
        <link>http://www.biomedcentral.com/1471-2474/13/83</link>
                <dc:creator>Pekka Kuittinen</dc:creator>
                <dc:creator>Timo Aalto</dc:creator>
                <dc:creator>Tapani Heikkilä</dc:creator>
                <dc:creator>Ville Leinonen</dc:creator>
                <dc:creator>Sakari Savolainen</dc:creator>
                <dc:creator>Petri Sipola</dc:creator>
                <dc:creator>Heikki Kröger</dc:creator>
                <dc:creator>Veli Turunen</dc:creator>
                <dc:creator>Olavi Airaksinen</dc:creator>
                <dc:source>BMC Musculoskeletal Disorders 2012, null:83</dc:source>
        <dc:date>2012-05-29T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2474-13-83</dc:identifier>
                                <prism:require>/content/figures/1471-2474-13-83-toc.gif</prism:require>
                <prism:publicationName>BMC Musculoskeletal Disorders</prism:publicationName>
        <prism:issn>1471-2474</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>83</prism:startingPage>
        <prism:publicationDate>2012-05-29T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2474/13/82">
        <title>Prevalence of chronic musculoskeletal disorders in elderly Brazilians: a systematic review of the literature</title>
        <description>Background:
Population ageing is a worldwide phenomenon that has recently challenged public healthcare systems. The knowledge of the burden of chronic musculoskeletal disorders in elders is still limited, particularly in the developing world. This systematic review aimed to investigate the prevalence of chronic musculoskeletal disorders in elderly Brazilians.
Methods:
A comprehensive literature search was performed in five electronic databases (from inception to January 2012) and completed by additional searches in reference lists. Two review authors independently selected the eligible studies and extracted data on participants&apos; characteristics and rates of chronic musculoskeletal disorders. One review author extracted methodological quality data. We performed a critical synthesis of the results, which were grouped into the diagnoses &quot;chronic musculoskeletal pain&quot; or &quot;specific musculoskeletal diagnoses&quot;.
Results:
Twenty three studies reporting on a total of 116,091 elderly Brazilians were included. Eight studies (35%) were of high methodological quality. There was a large variation in the measure of prevalence used by individual studies and in their definition of chronic pain. Prevalence estimates reached 86% for chronic musculoskeletal pain in any location. Studies investigating multiple pain sites found the lower limb and the spine to be the most prevalent complaints (50% each). Arthritis and rheumatism (including osteoarthritis) were the most prevalent specific musculoskeletal diagnoses (9% to 40%), followed by herniated disc (6% to 27%).
Conclusions:
Despite the growth of the elderly population worldwide, high-quality research on the burden of chronic musculoskeletal disorders in the elderly is still scarce. Future healthcare research focusing on this age group should be a priority in developing countries since their public healthcare systems are not yet fully prepared to accommodate the needs of an aging population.</description>
        <link>http://www.biomedcentral.com/1471-2474/13/82</link>
                <dc:creator>Vivian Miranda</dc:creator>
                <dc:creator>Vivielle deCarvalho</dc:creator>
                <dc:creator>Luciana Machado</dc:creator>
                <dc:creator>João Dias</dc:creator>
                <dc:source>BMC Musculoskeletal Disorders 2012, null:82</dc:source>
        <dc:date>2012-05-29T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2474-13-82</dc:identifier>
                                <prism:require>/content/figures/1471-2474-13-82-toc.gif</prism:require>
                <prism:publicationName>BMC Musculoskeletal Disorders</prism:publicationName>
        <prism:issn>1471-2474</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>82</prism:startingPage>
        <prism:publicationDate>2012-05-29T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2474/13/81">
        <title>The effect of taping versus semi-rigid bracing on patient outcome and satisfaction in ankle sprains: a prospective, randomized controlled trial</title>
        <description>Background:
Functional treatment is a widely used and generally accepted treatment for ankle sprain. A meta-analysis comparing the different functional treatment options could not make definitive conclusions regarding the effectiveness, and until now, little was known about patient satisfaction in relation to the outcome.
Methods:
Patients with acute ankle sprain received rest, ice, compression and elevation with an compressive bandage at the emergency department. After 5-7 days, 100 patients with grade II and III sprains were randomized into two groups: one group was treated with tape and the other with a semi-rigid ankle brace, both for 4 weeks. Post-injury physical and proprioceptive training was standardized. As primary outcome parameter patient satisfaction and skin complications were evaluated using a predefined questionnaire and numeric rating scale. As secondary outcome parameter the ankle joint function was assessed using the Karlsson scoring scale and range of motion.
Results:
Patient-reported comfort and satisfaction during treatment with a semi-rigid brace was significantly increased. The rate of skin complication in this group was significantly lower compared to the tape group (14.6% versus 59.1%, P&lt;0.0001). Functional outcome of the ankle joint was similar between the two treatment groups, as well as reported pain.
Conclusion:
Treatment of acute ankle sprain with semi-rigid brace leads to significantly higher patient comfort and satisfaction, both with similar good outcome.Trial registration number: ISRCTN58932628</description>
        <link>http://www.biomedcentral.com/1471-2474/13/81</link>
                <dc:creator>Sacha Lardenoye</dc:creator>
                <dc:creator>Ed Theunissen</dc:creator>
                <dc:creator>Berry Cleffken</dc:creator>
                <dc:creator>Peter Brink</dc:creator>
                <dc:creator>Rob de Bie</dc:creator>
                <dc:creator>Martijn Poeze</dc:creator>
                <dc:source>BMC Musculoskeletal Disorders 2012, null:81</dc:source>
        <dc:date>2012-05-28T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2474-13-81</dc:identifier>
                                <prism:require>/content/figures/1471-2474-13-81-toc.gif</prism:require>
                <prism:publicationName>BMC Musculoskeletal Disorders</prism:publicationName>
        <prism:issn>1471-2474</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>81</prism:startingPage>
        <prism:publicationDate>2012-05-28T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2474/13/80">
        <title>Inter-rater reliability of the evaluation of muscular chains associated with posture alterations in scoliosis</title>
        <description>Background:
In the Global postural re-education (GPR) evaluation, posture alterations are associated with anterior or posterior muscular chain impairments. Our goal was to assess the reliability of the GPR muscular chain evaluation.
Methods:
Design: Inter-rater reliability study. Fifty physical therapists (PTs) and two experts trained in GPR assessed the standing posture from photographs of five youths with idiopathic scoliosis using a posture analysis grid with 23 posture indices (PI).  The PTs and experts indicated the muscular chain associated with posture alterations. The PTs were also divided into three groups according to their experience in GPR. Experts&apos; results (after consensus) were used to verify agreement between PTs and experts for muscular chain and posture assessments. We used Kappa coefficients (K) and the percentage of agreement (%A) to assess inter-rater reliability and intra-class coefficients (ICC) for determining agreement between PTs and experts.
Results:
For the muscular chain evaluation, reliability was moderate to substantial for 12 PI for the PTs (%A: 56 to 82; K: 0.42 to 0.76) and perfect for 19 PI for the experts. For posture assessment, reliability was moderate to substantial for 12 PI for the PTs (%A&gt; 60%; K: 0.42 to 0.75) and moderate to perfect for 18 PI for the experts (%A: 80 to 100; K: 0.55 to 1.00). The agreement between PTs and experts was good for most muscular chain evaluations (18 PI; ICC: 0.82 to 0.99) and PI (19 PI; ICC:  0.78 to 1.00).
Conclusions:
The GPR muscular chain evaluation has good reliability for most posture indices. GPR evaluation should help guide physical therapists in targeting affected muscles for treatment of abnormal posture patterns.</description>
        <link>http://www.biomedcentral.com/1471-2474/13/80</link>
                <dc:creator>Carole Fortin</dc:creator>
                <dc:creator>Debbie Feldman</dc:creator>
                <dc:creator>Clarice Tanaka</dc:creator>
                <dc:creator>Michelle Houde</dc:creator>
                <dc:creator>Hubert Labelle</dc:creator>
                <dc:source>BMC Musculoskeletal Disorders 2012, null:80</dc:source>
        <dc:date>2012-05-28T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2474-13-80</dc:identifier>
                                <prism:require>/content/figures/1471-2474-13-80-toc.gif</prism:require>
                <prism:publicationName>BMC Musculoskeletal Disorders</prism:publicationName>
        <prism:issn>1471-2474</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>80</prism:startingPage>
        <prism:publicationDate>2012-05-28T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2474/13/79">
        <title>Burden of osteoporotic fractures in primary health care in Catalonia (Spain): a population-based study.</title>
        <description>Background:
Knowledge on the epidemiology of non-hip fractures in Spain is limited and somewhat outdated. Using computerized primary care records from the SIDIAP database, we derived age and sex-specific fracture incidence rates for the region of Catalonia during the year 2009.
Methods:
The SIDIAP database contains quality-checked clinical information from computerized medical records of a representative sample of &gt;5,800,000 patients (80% of the population of Catalonia). We conducted a retrospective cohort study including all patients aged [greater than or equal to]50 years, and followed them from January 1 to December 31, 2009. Major osteoporotic fractures registered in SIDIAP were ascertained using ICD-10 codes and validated by comparing data to hospital admission and patient-reported fractures records. Incidence rates and 95% confidence intervals were calculated.
Results:
In total, 2,011,430 subjects were studied (54.6% women). Overall fracture rates were 10.91/1,000 person-years (py) [95%CI 10.89-10.92]: 15.18/1,000 py [15.15-15.21] in women and 5.78/1,000 py [5.76-5.79] in men. The most common fracture among women was wrist/forearm (3.86/1,000 py [3.74-3.98]), while among men it was clinical spine (1.25/1,000 py [1.18-1.33]). All fracture rates increased with age, but varying patterns were observed: while most of the fractures (hip, proximal humerus, clinical spine and pelvis) increased continuously with age, wrist and multiple rib fractures peaked at age 75-80 and then reached a plateau.
Conclusions:
Our study provides local estimates of age, sex and site-specific fracture burden in primary health care, which will be helpful for health-care planning and delivery. A proportion of fractures are not reported in primary care records, leading to underestimation of fracture incidence rates in these data.</description>
        <link>http://www.biomedcentral.com/1471-2474/13/79</link>
                <dc:creator>Aina Pagès-Castellà</dc:creator>
                <dc:creator>Cristina Carbonell-Abella</dc:creator>
                <dc:creator>Francesc Fina Avilés</dc:creator>
                <dc:creator>Maite Alzamora</dc:creator>
                <dc:creator>Jose Miguel Baena-Díez</dc:creator>
                <dc:creator>Daniel Martínez Laguna</dc:creator>
                <dc:creator>Xavier Nogués</dc:creator>
                <dc:creator>Adolfo Díez-Pérez</dc:creator>
                <dc:creator>Daniel Prieto-Alhambra</dc:creator>
                <dc:source>BMC Musculoskeletal Disorders 2012, null:79</dc:source>
        <dc:date>2012-05-28T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2474-13-79</dc:identifier>
                                <prism:require>/content/figures/1471-2474-13-79-toc.gif</prism:require>
                <prism:publicationName>BMC Musculoskeletal Disorders</prism:publicationName>
        <prism:issn>1471-2474</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>79</prism:startingPage>
        <prism:publicationDate>2012-05-28T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2474/13/78">
        <title>&apos;Osteo-cise: Strong Bones for Life&apos;: Protocol for a Community-based Randomised Controlled Trial of a Multi-modal Exercise and Osteoporosis Education Program for Older Adults at Risk of Falls and Fractures</title>
        <description>Background:
Osteoporosis affects over 220 million people worldwide, and currently there is no &apos;cure&apos; for the disease. Thus, there is a need to develop evidence-based, safe and acceptable prevention strategies at the population level that target multiple risk factors for fragility fractures to reduce the health and economic burden of the condition.
Methods:
The &apos;Osteo-cise: Strong Bones for Life&apos; study will investigate the effectiveness and feasibility of a multi-component targeted exercise, osteoporosis education/awareness and behavioural change program for improving bone health and muscle function, and reducing falls risk in community-dwelling older adults at an increased risk of fracture. Men and women aged 60 years or above will participate in an 18-month randomised controlled trial comprising a 12-month structured and supervised community-based program and a 6-month &apos;research to practise&apos; translational phase. Participants will be randomly assigned to either the &apos;Osteo-cise&apos; intervention or a self-management control group. The intervention will comprise a multi-modal exercise program incorporating high velocity progressive resistance training, moderate impact weight-bearing exercise and high challenging balance exercises performed three times weekly at local community-based fitness centres. A behavioural change program will be used to enhance exercise adoption and adherence to the program. Community-based osteoporosis education seminars will be conducted to improve participant knowledge and understanding of the risk factors and preventative measures for osteoporosis, falls and fractures. The primary outcomes measures, to be collected at baseline, 6, 12, and 18 months, will include DXA-derived hip and spine bone mineral density measurements and functional muscle power (timed stair-climb test). Secondary outcomes measures include: MRI-assessed distal femur and proximal tibia trabecular bone micro-architecture, lower limb and back maximal muscle strength, balance and function (four square step test, functional reach test, timed up-and-go test and 30-second sit-to-stand), falls incidence and health-related quality of life. Cost-effectiveness will also be assessed.DiscussionThe findings from the Osteo-cise: Strong Bones for Life study will provide new information on the efficacy of a targeted multi-modal community-based exercise program incorporating high velocity resistance training, together with an osteoporosis education and behavioural change program for improving multiple risk factors for falls and fracture in older adults at risk of fragility fracture.Trial Registration: Australian New Zealand Clinical Trials Registry reference ACTRN12609000100291</description>
        <link>http://www.biomedcentral.com/1471-2474/13/78</link>
                <dc:creator>Jenny Gianoudis</dc:creator>
                <dc:creator>Christine Bailey</dc:creator>
                <dc:creator>Kerrie Sanders</dc:creator>
                <dc:creator>Caryl Nowson</dc:creator>
                <dc:creator>Keith Hill</dc:creator>
                <dc:creator>Peter Ebeling</dc:creator>
                <dc:creator>Robin Daly</dc:creator>
                <dc:source>BMC Musculoskeletal Disorders 2012, null:78</dc:source>
        <dc:date>2012-05-28T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2474-13-78</dc:identifier>
                                <prism:require>/content/figures/1471-2474-13-78-toc.gif</prism:require>
                <prism:publicationName>BMC Musculoskeletal Disorders</prism:publicationName>
        <prism:issn>1471-2474</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>78</prism:startingPage>
        <prism:publicationDate>2012-05-28T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2474/13/77">
        <title>Study protocol: Transition from localized low back pain to chronic widespread pain in general practice: Identification of risk factors, preventive factors and key elements for treatment - A cohort study</title>
        <description>Background:
Chronic localized pain syndromes, especially chronic low back pain (CLBP), are common reasons for consultation in general practice. In some cases chronic localized pain syndromes can appear in combination with chronic widespread pain (CWP). Numerous studies have shown a strong association between CWP and several physical and psychological factors. These studies are population-based cross-sectional and do not allow for assessing chronology.There are very few prospective studies that explore the predictors for the onset of CWP, where the main focus is identifying risk factors for the CWP incidence. Until now there have been no studies focusing on preventive factors keeping patients from developing CWP. Our aim is to perform a cross sectional study on the epidemiology of CLBP and CWP in general practice and to look for distinctive features regarding resources like resilience, selfefficacy and coping strategies. A subsequent cohort study is designed to identify the risk and protective factors of pain generalization (development of CWP) in primary care for CLBPpatients.
Methods:
Fifty-nine general practitioners recruit consecutively, during a 5 month period, all patients who are consulting their family doctor because of chronic low back pain (where the pain is lasted for 3 months). Patients are asked to fill out a questionnaire on pain anamnesis, painperception, co-morbidities, therapy course, medication, socio demographic data and psychosomatic symptoms. We assess resilience, coping resources, stress management and self-efficacy as potential protective factors for pain generalization. Furthermore, we raise risk factors for pain generalization like anxiety, depression, trauma and critical life events. During a twelve months follow up period a cohort of CLBP patients without CWP will be screened on a regular basis (3 monthly) for pain generalization (outcome: incident CWP).DiscussionThis cohort study will be the largest study which prospectively analyzes predictors for transition from CLBP to CWP in primary care setting. In contrast to the typically researched risk factors, which increase the probability of pain generalization, this study also focus intensively on protective factors, which decrease the probability of pain generalization.Trial registrationGerman Clinical Trial Register DRKS00003123</description>
        <link>http://www.biomedcentral.com/1471-2474/13/77</link>
                <dc:creator>Annika Viniol</dc:creator>
                <dc:creator>Nikita Jegan</dc:creator>
                <dc:creator>Corinna Leonhardt</dc:creator>
                <dc:creator>Konstantin Strauch</dc:creator>
                <dc:creator>Markus Brugger</dc:creator>
                <dc:creator>Jürgen Barth</dc:creator>
                <dc:creator>Erika Baum</dc:creator>
                <dc:creator>Annette Becker</dc:creator>
                <dc:source>BMC Musculoskeletal Disorders 2012, null:77</dc:source>
        <dc:date>2012-05-25T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2474-13-77</dc:identifier>
                                <prism:require>/content/figures/1471-2474-13-77-toc.gif</prism:require>
                <prism:publicationName>BMC Musculoskeletal Disorders</prism:publicationName>
        <prism:issn>1471-2474</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>77</prism:startingPage>
        <prism:publicationDate>2012-05-25T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2474/13/76">
        <title>Genetic contribution of catechol-Omethyltransferase variants in treatment outcome of low back pain: a prospective genetic association study</title>
        <description>Background:
Treatment outcome of low back pain (LBP) is associated with inter-individual variations in pain relief and functional disability. Genetic variants of catechol-O-methyltransferase (COMT) gene have previously been shown to be associated with pain sensitivity and pain medication. This study examines the association between COMT polymorphisms and 7-11 year change in Oswestry Disability Index (ODI) and Visual Analog Score (VAS) for LBP as clinical outcome variables in patients treated with surgical instrumented lumbar fusion or cognitive intervention and exercise.
Methods:
93 unrelated patients with chronic LBP for duration of &gt;1 year and lumbar disc degeneration (LDD) were treated with lumbar fusion (N = 60) or cognitive therapy and exercises (N = 33). Standardised questionnaires assessing the ODI, VAS LBP, psychological factors and use of analgesics, were answered by patients both at baseline and at 7-11 years follow-up. Four SNPs in the COMT gene were successfully genotyped. Single marker as well as haplotype association with change in ODI and VAS LBP, were analyzed using Haploview, linear regression and R-package Haplostats. P-values were not formally corrected for multiple testing as this was an explorative study.
Results:
Association analysis of individual SNPs adjusted for covariates revealed association of rs4633 and rs4680 with post treatment improvement in VAS LBP (p = 0.02, mean difference (beta) = 13.5 and p = 0.02, beta = 14.2 respectively). SNPs, rs4633 and rs4680 were found to be genotypically similar and in strong linkage disequilibrium (LD). A significant association was found with covariates, analgesics (p = 0.001, beta = 18.6); anxiety and depression (p = 0.008, beta = 15.4) and age (p = 0.03, mean difference per year (beta) = 0.7) at follow-up. There was a tendency for better improvement among heterozygous patients compared to the homozygous. No association was observed for the analysis of the common haplotypes, these SNPs were situated on.
Conclusions:
Results suggest an influence of genetic variants of COMT gene in describing the variation in pain after treatment for low back pain. Replication in large samples with testing for other pain related genes is warranted.</description>
        <link>http://www.biomedcentral.com/1471-2474/13/76</link>
                <dc:creator>Ahmad Omair</dc:creator>
                <dc:creator>Benedicte Lie</dc:creator>
                <dc:creator>Olav Reikeras</dc:creator>
                <dc:creator>Marit Holden</dc:creator>
                <dc:creator>Jens Brox</dc:creator>
                <dc:source>BMC Musculoskeletal Disorders 2012, null:76</dc:source>
        <dc:date>2012-05-21T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2474-13-76</dc:identifier>
                                <prism:require>/content/figures/1471-2474-13-76-toc.gif</prism:require>
                <prism:publicationName>BMC Musculoskeletal Disorders</prism:publicationName>
        <prism:issn>1471-2474</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>76</prism:startingPage>
        <prism:publicationDate>2012-05-21T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
        <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks" />
    </cc:License>
</rdf:RDF>

